复发性复发性多发性硬化症患者的形式限制和复发发作
Barbara Blaylock1, Karen Van Nuys2, Geoffrey Joyce2,3
1Blaylock Health Economics LLC, Reno, Nevada.
JAMA network open
|August 1, 2025
概括
多发性硬化症 (MS) 疾病修饰疗法 (DMT) 的更广泛配方覆盖与更少的复发有关. 这表明,为更好的多发性硬化护理,量身定制表单限制以满足患者需求,而不仅仅是成本管理,至关重要.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 药物经济学 药物经济学
- 神经学 神经学
背景情况:
- 狭窄的配方被用来谈判更高的折扣和控制在美国昂贵的药物上的支出.
- 了解表单宽度对患者结果的影响对于医疗保健政策至关重要.
研究的目的:
- 调查多发性硬化症 (MS) 疾病修饰疗法 (DMT) 的配方覆盖范围与MS复发的发生之间的关联.
- 评估医疗保险D部分计划中的表单设计如何影响MS患者的临床结果.
主要方法:
- 一个回顾性队列研究使用100%的医疗保险行政数据从2018-2022.
- 分析包括拥有独立处方药计划 (PDP) 和医疗保险优势处方药计划 (MA-PD) 的受益人,重点关注复发性复发性MS和DMT使用者.
- 形式宽度被归类为低或高覆盖范围,基于MS DMT或四季度药物类别的中位覆盖范围.
主要成果:
- 该研究分析了PDP的50,162名受益者和MA-PD的34,708名受益者.
- 更高的配方药覆盖率与较低的MS复发率有关:高覆盖率的PDPs中有9.5%,低覆盖率的PDPs中有10.6%,高覆盖率的MA-PDs中有6.9%,低覆盖率的MA-PDs中有7.8%.
- 多变量分析表明,更广泛的配方药覆盖率与减少多发性硬化症复发的几率显著相关 (调整后的ORs从0.88到0.94).
结论:
- 对MS DMTs的更广泛的配方覆盖与医疗保险受益人中MS复发风险降低有关.
- 这些发现表明,配方药的决策应该优先考虑患者的需求和临床结果,而不是仅仅管理药物成本和利用.
- 优化表单设计可以改善多发性硬化症的管理,并可能减少与复发相关的医疗保健支出.
相关概念视频
Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
439
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
439
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
Psychosis: Goals of Pharmacotherapy
208
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
208
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Drug Dependence
1.2K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.2K


